A detailed history of Price T Rowe Associates Inc transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 2,832,512 shares of AGIO stock, worth $100 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,832,512
Previous 2,777,259 1.99%
Holding current value
$100 Million
Previous $120 Million 5.09%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$41.19 - $49.72 $2.28 Million - $2.75 Million
55,253 Added 1.99%
2,832,512 $126 Million
Q2 2024

Aug 14, 2024

BUY
$27.55 - $48.83 $21.1 Million - $37.3 Million
764,266 Added 37.97%
2,777,259 $120 Million
Q1 2024

May 15, 2024

BUY
$21.32 - $34.81 $8.28 Million - $13.5 Million
388,381 Added 23.91%
2,012,993 $58.9 Million
Q4 2023

Feb 14, 2024

SELL
$19.97 - $24.53 $29,915 - $36,745
-1,498 Reduced 0.09%
1,624,612 $36.2 Million
Q3 2023

Nov 14, 2023

BUY
$24.36 - $28.18 $8.11 Million - $9.38 Million
332,718 Added 25.72%
1,626,110 $40.2 Million
Q2 2023

Aug 14, 2023

BUY
$21.38 - $29.19 $634,879 - $866,797
29,695 Added 2.35%
1,293,392 $36.6 Million
Q1 2023

May 15, 2023

SELL
$21.74 - $30.93 $4.71 Million - $6.7 Million
-216,497 Reduced 14.63%
1,263,697 $29 Million
Q4 2022

Feb 14, 2023

BUY
$24.81 - $31.52 $92,318 - $117,285
3,721 Added 0.25%
1,480,194 $41.6 Million
Q3 2022

Nov 14, 2022

SELL
$19.51 - $34.14 $20.9 Million - $36.5 Million
-1,070,513 Reduced 42.03%
1,476,473 $41.8 Million
Q2 2022

Aug 15, 2022

SELL
$17.06 - $31.42 $2.64 Million - $4.86 Million
-154,639 Reduced 5.72%
2,546,986 $56.5 Million
Q1 2022

May 16, 2022

SELL
$26.68 - $34.81 $4.72 Million - $6.16 Million
-177,089 Reduced 6.15%
2,701,625 $78.6 Million
Q4 2021

Feb 14, 2022

SELL
$29.58 - $49.78 $4.5 Million - $7.57 Million
-152,027 Reduced 5.02%
2,878,714 $94.6 Million
Q3 2021

Nov 15, 2021

BUY
$41.92 - $58.18 $1.99 Million - $2.76 Million
47,518 Added 1.59%
3,030,741 $140 Million
Q2 2021

Aug 16, 2021

BUY
$52.06 - $61.27 $1.19 Million - $1.4 Million
22,811 Added 0.77%
2,983,223 $164 Million
Q1 2021

May 17, 2021

SELL
$44.23 - $57.5 $526,779 - $684,825
-11,910 Reduced 0.4%
2,960,412 $153 Million
Q4 2020

Feb 16, 2021

BUY
$33.21 - $46.54 $98.7 Million - $138 Million
2,972,322 New
2,972,322 $129 Million

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $1.94B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.